Identification of Amino Acid Residues Important for Ligand Binding to Fas

por Starling, Gary C., Bajorath, Jürgen, Emswiler, John, Ledbetter, Jeffrey A., Aruffo, Alejandro, Kiener, Peter A.
Publicado 1997

Engineering Oncolytic Coxsackievirus A21 with Small Transgenes and Enabling Cell-Mediated Virus Delivery by Integrating Viral cDNA into the Genome

por Sam, Miranda, Selman, Mohammed, Zhao, Weilong, Jung, Jiwon, Willingham, Aarron, Phan, Uyen, Starling, Gary C., Gao, Qinshan
Publicado 2023

Differential Induction of Apoptosis by Fas–Fas Ligand Interactions in Human Monocytes and Macrophages

por Kiener, Peter A., Davis, Patricia M., Starling, Gary C., Mehlin, Christopher, Klebanoff, Seymour J., Ledbetter, Jeffrey A., Liles, W. Conrad
Publicado 1997

Elotuzumab enhances natural killer cell activation and myeloma cell killing through interleukin-2 and TNF-α pathways

por Balasa, Balaji, Yun, Rui, Belmar, Nicole A., Fox, Melvin, Chao, Debra T., Robbins, Michael D., Starling, Gary C., Rice, Audie G.
Publicado 2014

Enavatuzumab, a Humanized Anti-TWEAK Receptor Monoclonal Antibody, Exerts Antitumor Activity through Attracting and Activating Innate Immune Effector Cells

por Ye, Shiming, Fox, Melvin I., Belmar, Nicole A., Sho, Mien, Chao, Debra T., Choi, Donghee, Fang, Yuni, Zhao, Vivian, Keller, Stephen F., Starling, Gary C., Culp, Patricia A.
Publicado 2017

Nuclear Factor κB is Required for Tumor Growth Inhibition Mediated by Enavatuzumab (PDL192), a Humanized Monoclonal Antibody to TweakR

por Purcell, James W., Kim, Han K., Tanlimco, Sonia G., Doan, Minhtam, Fox, Melvin, Lambert, Peter, Chao, Debra T., Sho, Mien, Wilson, Keith E., Starling, Gary C., Culp, Patricia A.
Publicado 2014

Expression of TweakR in breast cancer and preclinical activity of enavatuzumab, a humanized anti-TweakR mAb

por Chao, Debra T., Su, Mian, Tanlimco, Sonia, Sho, Mien, Choi, Donghee, Fox, Mel, Ye, Shiming, Hsi, Eric D., Durkin, Lisa, Yin, Johnny, Zhang, Yongke, Kim, Han, Starling, Gary C., Culp, Patricia A.
Publicado 2012

PDL241, a novel humanized monoclonal antibody, reveals CD319 as a therapeutic target for rheumatoid arthritis

por Woo, Jacky, Vierboom, Michel PM, Kwon, Hakju, Chao, Debra, Ye, Shiming, Li, Jianmin, Lin, Karen, Tang, Irene, Belmar, Nicole A, Hartman, Taymar, Breedveld, Elia, Vexler, Vladimir, ‘t Hart, Bert A, Law, Debbie A, Starling, Gary C
Publicado 2013